{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/84549-003#drug","name":"Revonto","alternateName":"dantrolene sodium","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"84549-003"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA078378"},{"@type":"PropertyValue","propertyID":"UNII","value":"287M0347EV"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"3edcfad5-00ad-7587-e063-6394a90addf3"}],"activeIngredient":"DANTROLENE SODIUM","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"ProPharma Distribution"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA078378","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3edcfad5-00ad-7587-e063-6394a90addf3","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84549-003"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T10:56:25.687Z"}}